Treatment of membranous nephropathy in the elderly

Seminars in Nephrology

Volumn 23, Issue 4, 2003, Pages 373-378

  Abrass, Christine K ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROBUCOL; RAPAMYCIN; TACROLIMUS;

AGED; AGING; DISEASE COURSE; DOSE CALCULATION; EDEMA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOMA; MEMBRANOUS GLOMERULONEPHRITIS; MORBIDITY; MORTALITY; NEPHROTIC SYNDROME; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SIDE EFFECT; SKIN CANCER; SODIUM RETENTION; VASCULAR DISEASE;

EID: 0041887389     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0270-9295(03)00053-6     Document Type: Article

References (33)

1. Cattran DC: Management of membranous nephropathy. Minerva Urol Nefrol 54:19-27, 2002
2. Zent R, Nagai R, Cattran DC: Idiopathic membranous nephropathy in the elderly: A comparative study. Am J Kidney Dis 29:200-206, 1997
3. Branten AJ, Wetzels JF: Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Clin Nephrol 56:1-9, 2001
4. Glassock RJ: Glomenular disease in the elderly population. Geriatr Nephrol Urol 8:149-154, 1998
5. Shin JH, Pyo HJ, Kwon YJ, et al: Renal biopsy in elderly patients: Clinicopathological correlation in 117 Korean patients. Clin Nephrol 56:19-26, 2001
6. Couser WC, Alpers CE: Membranous nephropathy, in Neilson EG, Couser WC (eds): Immunologic Renal Diseases. New York, Lippincott Williams & Wilkins, 2001, pp 1029-1055
7. Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med 80:435-442, 1986
8. O'Callaghan CA, Hicks J, Doll H, et al: Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 33:157-165, 2002
9. Davison AM: Renal disease in the elderly. Nephron 80:6-16, 1998
10. Clark B: Biology of renal aging in humans. Adv Ren Replace Ther 7:11-21, 2000
11. Anderson S, Brenner BM: The aging kidney: Structure, function, mechanisms, and therapeutic implications. J Am Geriatr Soc 35:590-593, 1987
12. Takazakura E, Sawabu N, Handa A, et al: Intrarenal vascular changes with age and disease. Kidney Int 2:224-230, 1972
13. Garg AX, Kiberd BA, Clark WF, et al: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61:2165-2175, 2002
14. Baylis C, Fredericks M, Leypoldt K, et al: Mechanisms of proteinuria in aging rats. Mech Ageing Dev 45:111-126, 1988
15. Bengele HH, Mathias RS, Perkins JH, et al: Urinary concentrating defect in the aged rat. Am J Physiol 240:F147-F150, 1981
16. Kunis CL, Teng SN: Treatment of glomerulonephritis in the elderly. Semin Nephrol 20:256-264, 2000
17. Torres A, Dominguez-Gil B, Carreno A, et al: Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 61:349-350, 2002
18. Abrass CK: Clinical spectrum and complications of the nephrotic syndrome. J Investig Med 45:143-153, 1997
19. Haas M, Mayer G, Wirnsberger G, et al: Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: A pilot study. Wien Klin Wochenschr 114:143-147, 2002
20. Hirokawa K, Utsuyama M: Animal models and possible human application of immunological restoration in the elderly, Mech Ageing Dev 123:1055-1063, 2002
21. Saurwein-Teissl M, Lung TL, Marx F, et al: Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168:5893-5899, 2002
22. Dailey RW, Eun SY, Russell CE, et al: B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function, Cell Immunol 214:99-109, 2001
23. Renshaw M, Rockwell J, Engleman C, et al: Cutting edge: Impaired toll-like receptor expression and function in aging. J Immunol 169:4697-4701, 2002
24. Garcia GG, Miller RA: Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells. J Immunol 169:5021-5027, 2002
25. Uyemura K, Castle SC, Makinodan T: The frail elderly: Role of dendritic cells in the susceptibility of infection. Mech Ageing Dev 123:955-962, 2002
26. Stacy S, Krolick KA, Infante AJ, et al: Immunological memory and late onset autoimmunity. Mech Ageing Dev 123:975-985, 2002
27. Khan N, Shariff N, Cobbold M, et al: Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169:1984-1992, 2003
28. Jansen PL: Liver disease in the elderly. Best Pract Res Clin Gastroenterol 16:149-158, 2002
29. Zeeh J, Platt D: The aging liver: Structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121-127, 2002
30. Beale E, Zhu J, Belzberg H: Changes in serum cortisol with age in critically ill patients, Gerontology 48:84-92, 2002
31. Yao X, Chen H, Wang Q, et al: Cyclosporin A treatment of idiopathic membranous nephropathy. Chin Med J 114:1305-1308, 2001
32. Miller G, Zimmerman RI, Radhakrishnan J, et al: Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 36:250-256, 2000
33. Choi MJ, Eustace JA, Gimenez LF, et al: Mycophenolate mofetil treatment of primary glomerular diseases, Kidney Int 61:1098-1114, 2002